SEC Filings
PMV Pharmaceuticals Completes $50 Million Offering, Extending Expected Funding Into 2028
Research spending fell, while warrant-related charges widened the quarterly loss ahead of a planned ovarian cancer approval application.
PMV Pharmaceuticals (PMVP) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Research spending fell, while warrant-related charges widened the quarterly loss ahead of a planned ovarian cancer approval application.
SEC Filings
The 8-K sets Eckler's term through the 2029 annual meeting, with a $40,000 cash retainer and an 84,000-share option grant.